icon-folder.gif   Conference Reports for NATAP  
 
  Paris Special EASL Meeting
Pais, France
September 23-24, 2016
Back grey_arrow_rt.gif
 
 
 
GARNET: High SVR Rates Following 8-Week Treatment With Ombitasvir/ Paritaprevir/Ritonavir + Dasabuvir in Patients With HCV Genotype 1b Infection
 
 
  Reported by Jules Levin
 
European Association for the Study of the Liver Special Conference, 23-24 September 2016, Paris, France
 
Tania M Welzel1, Stefan Zeuzem1, Emily O Dumas2, Tarik Asselah3, David Shaw4, Rawi Hazzan5, Xavier Forns6, Tami Pilot-Mathias3, Wenjing Lu3, Daniel E Cohen3, Jordan Feld7 1JW Goethe University, Frankfurt, Germany; 2AbbVie Inc., North Chicago, Illinois, United States; 3Centre de Recherche sur l'Inflammation, Inserm UMR 1149, UniversitÚ Paris Diderot, AP-HP H˘pital Beaujon, Clichy, France; 4Royal Adelaide Hospital, Adelaide, South Australia, Australia; 5Ha'emek Medical Center, Afula, Israel; 6Liver Unit, Hospital Clinic, CIBEREHD, IDIBAPS, Barcelona, Spain; 7Toronto Centre for Liver Disease, University of Toronto, Toronto, Ontario, Canada

IAC1

IAC2

IAC3

IAC4

IAC5

IAC6

IAC7

IAC8